News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
EIT stakeholder consultations launched
Published on | 4 years ago
Programmes FET ICT NMBP SPACE SME Instrument Health Food Energy Transport Climate/Environment Societies Security EIC Pilot Batteries Circular Industries Horizon 2020The European Institute of Innovation and Technology (EIT) has launched three consultations to gather input from stakeholders and to inform their future activities.
- EIT Regional Innovation Scheme (EIT RIS) post-2020
- New EIT Action to support the innovation capacity of Higher Education Institutions (HEIs)
- EIT Community – Open and Inclusive
The surveys will close on 15 November 2020.
Related News
|
2024-10-15
|
3 months ago |
Annual report on implementation of the EU budget for the financial year 2023 by Eur... |
|
2024-02-15
|
11 months ago |
Horizon 2020 final evaluation |
|
2023-10-09
|
1 year ago |
Last few days to respond to survey: help us further improve NCP Flanders services |
|
2023-09-27
|
1 year ago |
NCP Flanders survey still open until 13 October |
|
2023-08-21
|
1 year ago |
NCP Flanders survey: looking for your feedback |
|
2023-06-26
|
1 year ago |
Call for applications for members of the European Commission expert group on Horizon... |
|
2023-06-09
|
1 year ago |
COM 2022 Report on Research and Technological Development Activities |
|
2023-06-08
|
1 year ago |
Industry 5.0 Award 2023- open for submission |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1517 articles available search in articlesTestimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
